Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01509053
What this trial is testing

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Not applicableLooking for participantsNCT07696000
What this trial is testing

The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy

Who this might be right for
Schizophrenia / Schizoaffective Disorder
DINA KEUMALA SARI 100
Large-scale testing (Phase 3)Looking for participantsNCT07606014
What this trial is testing

No Guts No Glory Probiotics

Who this might be right for
Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine
University Medical Center Groningen 112
Not applicableEnrolling By InvitationNCT07130500
What this trial is testing

Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

Who this might be right for
Schizophrenia DisorderSchizoaffective DisorderBipolar Disorder (BD)+1 more
Stanford University 1,000
Post-approval studies (Phase 4)Study completedNCT00649064
What this trial is testing

The Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs

Who this might be right for
Schizoaffective DisorderSchizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 46
Post-approval studies (Phase 4)Study completedNCT00845988
What this trial is testing

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

Who this might be right for
Bipolar DisordersMetabolic Complication
Seoul National University Hospital 28
Post-approval studies (Phase 4)Study completedNCT01578486
What this trial is testing

Salsalate as an Adjunctive Treatment for Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Massachusetts, Worcester 17
Not applicableStudy completedNCT02874560
What this trial is testing

Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia

Who this might be right for
Schizophrenia
Janssen-Cilag Ltd. 364
Post-approval studies (Phase 4)Looking for participantsNCT04478838
What this trial is testing

"Extended" (Alternate Day) Antipsychotic Dosing

Who this might be right for
Schizophrenia and Related DisordersDrug Administration ScheduleDrug Therapy+1 more
Centre for Addiction and Mental Health 120
Post-approval studies (Phase 4)Study completedNCT01206153
What this trial is testing

Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients

Who this might be right for
Amenorrhea
Central South University 84
Testing effectiveness (Phase 2)Study completedNCT03818256
What this trial is testing

Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)
Corcept Therapeutics 71
Post-approval studies (Phase 4)Ended earlyNCT00712270
What this trial is testing

Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia

Who this might be right for
Schizophrenia
Kettering Health Network 21
Post-approval studies (Phase 4)UnknownNCT03080194
What this trial is testing

The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Maosheng Fang 150
Post-approval studies (Phase 4)Study completedNCT01920802
What this trial is testing

Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo

Who this might be right for
Healthy
New York State Psychiatric Institute 31
Not applicableStudy completedNCT00344500
What this trial is testing

Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications

Who this might be right for
DiabetesObesityWeight Gain
VA Office of Research and Development 122
Not applicableStudy completedNCT00167934
What this trial is testing

Determining Metabolic Effects of Valproate and Antipsychotic Therapy

Who this might be right for
Schizophrenia
Washington University School of Medicine 164
Not applicableStudy completedNCT00818298
What this trial is testing

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Who this might be right for
SchizophreniaSchizoaffective Disorder
Centre for Addiction and Mental Health 12
Post-approval studies (Phase 4)Study completedNCT00433121
What this trial is testing

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

Who this might be right for
Dementia
Sykehuset Innlandet HF 24
Not applicableStudy completedNCT04076371
What this trial is testing

The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Beijing HuiLongGuan Hospital 1,640
Post-approval studies (Phase 4)UnknownNCT00469664
What this trial is testing

Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderCognitive Impairment
Research Foundation for Mental Hygiene, Inc. 50
Next Page